Tumor Proliferative Activity is Predictive of Pathological Stage in Clinical Stage a Nonseminomatous Testicular Germ Cell Tumors
- 1 February 1996
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 155 (2) , 579-586
- https://doi.org/10.1016/s0022-5347(01)66454-1
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Predictive parameters of biologic behavior of early stage nonseminomatous testicular germ cell tumorsCancer, 1994
- Flow‐cytometric and quantitative histologic parameters as prognostic indicators for occult retroperitoneal disease in clinical‐stage‐I non‐seminomatous testicular germ‐cell tumorsInternational Journal of Cancer, 1994
- Flow Cytometric and Quantitative Histological Parameters to Predict Occult Disease in Clinical Stage I Nonseminomatous Testicular Germ Cell TumorsJournal of Urology, 1993
- Primary Retroperitoneal Lymph Node Dissection in Clinical Stage A Non‐seminomatous Germ Cell Testis Cancer Review of the Indiana University Experience 1965–1989British Journal of Urology, 1993
- Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party.Journal of Clinical Oncology, 1992
- Comparison between Clinical and Pathological Staging in Low Stage Nonseminomatous Germ Cell Testicular TumorsJournal of Urology, 1992
- Treatment of testicular cancer: a new and improved model.Journal of Clinical Oncology, 1990
- Risk-adapted treatment choice in stage I nonseminomatous testicular germ cell cancer by regarding vascular invasion in the primary tumor: a prospective trial.Journal of Clinical Oncology, 1990
- HISTOPATHOLOGY IN THE PREDICTION OF RELAPSE OF PATIENTS WITH STAGE I TESTICULAR TERATOMA TREATED BY ORCHIDECTOMY ALONEThe Lancet, 1987
- ORCHIDECTOMY ALONE IN TESTICULAR STAGE I NON-SEMINOMATOUS GERM-CELL TUMOURSThe Lancet, 1982